Michael Exton bought $50K of Lexicon Pharmaceuticals stock
By AlphaYouPublished Form 4
Exton Michael
Reporting filer
Michael Exton reported buying 30,064 shares of Lexicon Pharmaceuticals, Inc. for about $50K ($1.66 a share on average). Form 4 filed Nov 9, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 9, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Exton Michael | 2026-11-06 | P | Purchase | 30064 | 1.6631 | 328,496 | 3 days | Filed terms
|
Common Stock
- Owner
- Exton Michael
- Date
- 2026-11-06
- Code
- P
- Action
- Purchase
- Quantity
- 30064
- Price
- 1.6631
- Following holdings
- 328,496
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 30064
- transaction Price Per Share: 1.6631
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 328496
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Exton Michael: Chief Executive Officer, Director.
- F1: Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.63 to $1.67 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
Original sources
Prepared automatically from public filing data. Report a correction.